Completed

Motivational Enhancement Therapy (MET) to Improve Treatment Utilization in Pregnant Substance Users

0 criteria met from your profileSee at a glance how your profile meets each eligibility criteria.
What is being tested

Data Collection

Who is being recruted

Drug Misuse+1

+ Mental Disorders

+ Substance-Related Disorders

From 18 to 99 Years
See all eligibility criteria
How is the trial designed

Treatment Study

Phase 3
Interventional
Study Start: October 2003
See protocol details

Summary

Principal SponsorUniversity of Cincinnati
Last updated: January 14, 2026
Sourced from a government-validated database.Claim as a partner

Study start date: October 1, 2003

Actual date on which the first participant was enrolled.

The purpose of this study is to compare Motivational Enhancement Therapy (MET) with standard drug abuse treatment among pregnant women.

Official TitleMotivational Enhancement Therapy (MET) to Improve Treatment Utilization in Pregnant Substance Users 
NCT00078143
Principal SponsorUniversity of Cincinnati
Last updated: January 14, 2026
Sourced from a government-validated database.Claim as a partner

Protocol

This section provides details of the study plan, including how the study is designed and what the study is measuring.
Design Details

200 patients to be enrolled

Total number of participants that the clinical trial aims to recruit.

Treatment Study

These studies test new ways to treat a disease, condition, or health issue. The goal is to see if a new drug, therapy, or approach works better or has fewer side effects than existing options.

Eligibility

Researchers look for people who fit a certain description, called eligibility criteria: person's general health condition or prior treatments.
Conditions
Criteria

Female

Biological sex of participants that are eligible to enroll.

From 18 to 99 Years

Range of ages for which participants are eligible to join.

Healthy volunteers not allowed

If individuals who are healthy and do not have the condition being studied can participate.

Conditions

Pathology

Drug MisuseMental DisordersSubstance-Related DisordersChemically-Induced Disorders

Criteria

Inclusion Criteria: * Pregnancy \<30 weeks * Have not attended drug treatment in past 28 days * Not needing residential treatment (except detox) * Not at risk for suicide/homicide * Have no pending legal charges (except drug treatment)

Study Plan

Find out more about all the medication administered in this study, their detailed description and what they involve.
Study Objectives

Study Objectives

Primary Objectives

Study Centers

These are the hospitals, clinics, or research facilities where the trial is being conducted. You can find the location closest to you and its status.

This study has 6 locations

Suspended

Midtown Community Mental Health Center

Indianapolis, United StatesSee the location
Suspended

Jefferson Alcohol & Drug Abuse Center

Louisville, United States
Suspended

Eleonore Hutzel Recovery Center

Detroit, United States
Suspended

Milagro Clinic

Albuquerque, United States
Completed6 Study Centers